SMAD3 and prostate carcinoma: In this study, we further showed that docetaxel treatment significantly inhibited cell proliferation in prostate cancer cells by inhibition of Smad3-mediated tumor glycolysis, leading to decrease glucose uptake and lactate production, which illustrated a novel function of docetaxel in prostate cancer cells.